{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T13:25:49Z","timestamp":1781961949944,"version":"3.54.5"},"reference-count":63,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2004,11,1]]},"DOI":"10.1080\/10428190410001723278","type":"journal-article","created":{"date-parts":[[2004,8,12]],"date-time":"2004-08-12T06:22:30Z","timestamp":1092291750000},"page":"2197-2203","source":"Crossref","is-referenced-by-count":55,"title":["Clonal Cytogenetic Abnormalities in Philadelphia Chromosome Negative Cells in Chronic Myeloid Leukemia Patients Treated with Imatinib"],"prefix":"10.1080","volume":"45","author":[{"given":"Marc","family":"Loriaux","sequence":"first","affiliation":[{"name":"Department of Pathology and the Division of Hematology and Oncology Oregon Health & Science University Portland Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Deininger","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine Oregon Health & Science University Portland Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2009,7,1]]},"reference":[{"key":"CIT0001","first-page":"550\u2014 554","volume":"315","author":"Shtivelman E.","year":"1985","journal-title":"\"Fused transcript of abl and bcr genes in chronic myelogenous leukaemia\", Nature"},{"key":"CIT0002","first-page":"306, 277 \u2014 280","author":"Bartram CR.","year":"1983","journal-title":"Nature"},{"key":"CIT0003","unstructured":"Nowell, P.C. and Hungerford, D.A. (1960) \"A minute chromosome in human chronic ganulocytic leukemia\", Science, 132, 1497. Abstract."},{"key":"CIT0004","first-page":"290","volume":"243","author":"Rowley J.D","year":"1973","journal-title":"A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quina-crine fluorescence and Giemsa staining\", Nature"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1126\/science.2406902"},{"key":"CIT0006","unstructured":"Cervantes, F. (2003) \"Durability of responses to Imatinib in newly diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML): 24-Month Update from the IRIS Study\", Blood, 102, 181a. Abstract."},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011573"},{"key":"CIT0008","first-page":"994","volume":"348","author":"O'Brien S.G.","year":"2003","journal-title":"J. Med"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910180105"},{"key":"CIT0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1600-0609.1976.tb02836.x","author":"Lawler S.D","year":"1976","journal-title":"Scand. J. HaematoL"},{"key":"CIT0011","first-page":"1134 \u2014 1138","volume":"10","author":"Johansson B.","year":"1996","journal-title":"\"Abberant cytogenetic evolution pattern of Philadelphia-positive chronic myeloid leukemia treated with interferon-alpha\", Leukemia"},{"key":"CIT0012","first-page":"385","volume":"18","author":"Nanjangud G.","year":"1994","journal-title":"Res"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(85)90041-X"},{"key":"CIT0014","doi-asserted-by":"crossref","unstructured":"Hild, F., Freund, M. and Fonatsch, C. (1991) \"Chromosomal aberrations during interferon therapy for chronic myelogenous leukemia\", N. Engl. J. Med., 325, 132. Letter.","DOI":"10.1056\/NEJM199107113250214"},{"key":"CIT0015","first-page":"172 \u2014 176","volume":"113","author":"Maloisel F.","year":"1999","journal-title":"Cytogenet"},{"key":"CIT0016","first-page":"27, 278 \u2014 284","author":"Chase A.","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"CIT0017","first-page":"263","volume":"9","author":"Bilhou-Nabera C.","year":"1992","journal-title":"\"Serial cytogenetic studies in allografted patients with chronic myeloid leukemia\", Bone Marrow Transplant"},{"key":"CIT0018","first-page":"69\u2014 78","volume":"57","author":"Sessarego M.","year":"1991","journal-title":"Cytogenet"},{"key":"CIT0019","first-page":"88, 260\u2014 267","author":"Marktel S.","year":"2003","journal-title":"Haematologica"},{"key":"CIT0020","first-page":"1333","author":"Mohamed AN.","year":"2003","journal-title":"Clin Cancer Res"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.2870060414"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(94)00197-9"},{"key":"CIT0023","first-page":"4, 269 \u2014 270","author":"Casali M.","year":"1992","journal-title":"Genes Chromosomes Cancer"},{"key":"CIT0024","first-page":"73 \u2014 77","volume":"64","author":"Izumi T.","year":"1996","journal-title":"J. HematoL"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400642"},{"key":"CIT0026","unstructured":"Shepherd, P., Brito-Babapulle, F., Duncombe, A., Parker, A., Parry, H., Winfield, D., et al. (1996) \"Acute blast transformation in CML patients still showing cytogenetic response to IFN-nl and the presence of cytogenetic abnormalities in Ph negative cells\", Br. J. HaematoL, 93, 72. Abstract 282."},{"key":"CIT0027","first-page":"361 \u2014 362","volume":"18","author":"Alimena G.","year":"2004","journal-title":"clinical and biological features of a myelodysplastic syndrome\", Leukemia"},{"key":"CIT0028","first-page":"781","volume":"101","author":"Goldberg S.L.","year":"2003","journal-title":"implications for imatinib mesylate therapy\", Blood"},{"key":"CIT0029","first-page":"16, 1390\u2014 1393","author":"Andersen M.K.","year":"2002","journal-title":"Leukemia"},{"key":"CIT0030","unstructured":"Besalduch, J., Gutierrez, A., Rosell, J., Bernues, M. and Sampol, A. (2002) \"Abnormal cytogenetic evolution in a case of CML treated by imatinib mesylate\", Blood, 100, 33 lb."},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-2053"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2004.01310.x"},{"key":"CIT0033","first-page":"78 \u201480","volume":"147","author":"Herens C.","year":"2003","journal-title":"Cytogenet"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(03)00176-0"},{"key":"CIT0035","first-page":"313 \u2014 314","volume":"71","author":"Gozzetti A.","year":"2003","journal-title":"\"Emergence of Ph negative clones in chronic myeloid leukemia (CML) patients in complete cytogenetic remission after therapy with imatinib mesylate (STI)\", European Journal of Haematology"},{"key":"CIT0036","unstructured":"Gambacorti-Passerini, C., Giudici, G., le Coutre, P., Bungaro, S., Pogliani, E., Kreuzer, K.A., et al. (2001) \"Non random chromo-somal abnormalities in Ph-negative bone marrow (BM) cells from CML patients achieving major cytogenetic responses (MCR) with ST171 (GleevecTM)\", Blood, 98, 257b."},{"key":"CIT0037","first-page":"465","volume":"17","author":"Meeus P.","year":"2003","journal-title":"\"Sustained, clonal karyotype abnormal-ities in the Philadelphia chromosome negative cells of CML patients successfully treated with Imatinib\", Leukemia"},{"key":"CIT0038","unstructured":"Medina, J., Kantarjian, H., Talpaz, M., O'Brien, S., Garcia-Manero, G., Faderl, S., et al. (2002) \"Chromosomal abnormalities in Philadelphia chromosome (Ph) negative metaphases appearing during treatment with imatinib mesylate in patients (pts) with Ph positive chronic myeloid leukemia (CML) in chronic phase (CP)\", Blood, 100, 368a."},{"key":"CIT0039","doi-asserted-by":"crossref","unstructured":"McMullin, M.F., Humphreys, M., Byrne, J., Russell, N.H., Cuthbert, R.J. and O'Dwyer, M.E. (2003) \"Chromosomal abnorm-alities in Ph- cells of patients on imatinib\", Blood, 102, 2700\u2014 2701; author reply 2701.","DOI":"10.1182\/blood-2003-06-1943"},{"key":"CIT0040","first-page":"481","volume":"17","author":"O'Dwyer M.E.","year":"2003","journal-title":"\"Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate\", Leukemia"},{"key":"CIT0041","first-page":"461 \u2014463","volume":"17","author":"Schoch C.","year":"2003","journal-title":"\"Occurrence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylate\", Leukemia"},{"key":"CIT0042","unstructured":"Sun, G., Boczkowska, B., Tcheurekdjian, L., Lorenzo, M. and Owens, M. (2002) \"The emergence of cytogenetically unrelated clones may not be an uncommon finding in imatinib mesylate-treated CML\", Blood, 100, 326b. Abstract."},{"key":"CIT0043","unstructured":"Snyder, D.S., Slovak, M.L., Bhatia, R. and Arber, D. (2002) \"Philadelphia chromosome negative clones in Philadelphia chromo-some positive CML: emerging clinical implications in eight cases\", Blood, 100, 322b. Abstract."},{"key":"CIT0044","unstructured":"Symeonidis, A., Kouraklis-Symeonidis, A., Lambropoulou, V., Giannaloulas, N., Fragopanagou, E., Tinikou, M., et al. (2003) \"Emergence of Abnormal Cytogenetic Abnormalities after Treat-ment of Patients with bcr\/abl + Chronic Myelogenous Leukemia with Imatinib\", Blood, 102, 318b. Abstract."},{"key":"CIT0045","unstructured":"Meunier, V., Giraudier, S., Van den Aker, J., Perot, C., Jouault, H., Caron-Servan, B., et al. (2001) \"Treatment with STI571 (Novar-tisR) in chronic myeloid leukemia (CML): unexpected hematologi-cal findings in a series of 26 patients\", Blood, 98, 263b."},{"key":"CIT0046","author":"ISCN","year":"1995","journal-title":"An International System for Human Cytogenetic Nomenclature, edited by F"},{"key":"CIT0047","first-page":"17, 807 \u2014810","author":"Royer-Pokora B.","year":"2003","journal-title":"Leukemia"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.d01-1751.x"},{"key":"CIT0049","first-page":"1163","volume":"7","author":"Raskind W.H.","year":"1993","journal-title":"\"Further evidence for the existence of a clonal Ph-negative stage in some cases of Ph-positive chronic myelocytic leukemia\", Leukemia"},{"key":"CIT0050","first-page":"158 \u2014 163","volume":"58","author":"Fialkow P.J.","year":"1981","journal-title":"\"Evidence for a multistep pathogen-esis of chronic myelogenous leukemia\", Blood"},{"key":"CIT0051","first-page":"1397","volume":"27","author":"Spencer A.","year":"1999","journal-title":"He-matol"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb06755.x"},{"key":"CIT0053","doi-asserted-by":"crossref","unstructured":"Mauro, M.J., Loriaux, M. and Deininger, M.W. (2004) \"Ph-positive and -negative myeloproliferative syndromes may co-exist\", Leuke-mia.","DOI":"10.1038\/sj.leu.2403375"},{"key":"CIT0054","first-page":"172\u2014 175","volume":"145","author":"Ganti AK.","year":"2003","journal-title":"Cytogenet"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1038\/21704"},{"key":"CIT0056","first-page":"520","volume":"387","author":"Shafman T.","year":"1997","journal-title":"\"Interaction between ATM protein and c-Abl in response to DNA damage\", Nature"},{"key":"CIT0057","first-page":"732","volume":"386","author":"Kharbanda S.","year":"1997","journal-title":"\"Functional interaction between DNA-PK and c-Abl in response to DNA damage\", Nature"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.3.925"},{"key":"CIT0059","first-page":"994","volume":"19","author":"Lowry P.A.","year":"1991","journal-title":"Hematol"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.16.7420"},{"key":"CIT0061","first-page":"1101 \u2014 1134","volume":"91","author":"Lyman S.D.","year":"1998","journal-title":"stem\/progenitor cell factors with overlapping yet distinct activities\", Blood"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199905273402107"},{"key":"CIT0063","first-page":"479","volume":"14","author":"Olney, Hi. and Le Beau, M.M.","year":"2001","journal-title":"Clin. Haema-toL"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428190410001723278","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T04:38:12Z","timestamp":1705207092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428190410001723278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,1]]},"references-count":63,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,11,1]]}},"alternative-id":["10.1080\/10428190410001723278"],"URL":"https:\/\/doi.org\/10.1080\/10428190410001723278","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,1]]}}}